Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
12 août 2024 08h30 HE
|
Oragenics
– ONP-002 showed no cancer-causing DNA damage – Phase II clinical trial being planned SARASOTA, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on...
In Vivo Toxicology Market to Cross USD 9.5 Bn Revenue by 2033 | TMR Study
10 avr. 2023 15h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 11, 2023 (GLOBE NEWSWIRE) -- According to market research by TMR, the global in vivo toxicology industry is expected to witness significant growth during...
In-Vitro Toxicology/Toxicity Testing Market Worth $14.4 Billion by 2025, Growing at a CAGR of 9% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
23 juin 2020 13h45 HE
|
Meticulous Market Research Pvt. Ltd.
London, June 23, 2020 (GLOBE NEWSWIRE) -- Safety assessment of substances is essential to determine their toxic implications on humans and the environment. Toxicology studies evaluate the substances...